Distribution of Hematopoietic Stem Cells in the Bone Marrow According to Regional Hypoxia

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2007 Mar 22

PMID 17374716

Citations 379

Authors

Kalindi Parmar

Peter Mauch

Jo-Anne Vergilio

Robert Sackstein

Julian D Down

Affiliations

Soon will be listed here.

Abstract

The interaction of stem cells with their bone marrow microenvironment is a critical process in maintaining normal hematopoiesis. We applied an approach to resolve the spatial organization that underlies these interactions by evaluating the distribution of hematopoietic cell subsets along an in vivo Hoechst 33342 (Ho) dye perfusion gradient. Cells isolated from different bone marrow regions according to Ho fluorescence intensity contained the highest concentration of hematopoietic stem cell (HSC) activity in the lowest end of the Ho gradient (i.e., in the regions reflecting diminished perfusion). Consistent with the ability of Ho perfusion to simulate the level of oxygenation, bone marrow fractions separately enriched for HSCs were found to be the most positive for the binding of the hypoxic marker pimonidazole. Moreover, the in vivo administration of the hypoxic cytotoxic agent tirapazamine exhibited selective toxicity to the primitive stem cell subset. These data collectively indicate that HSCs and the supporting cells of the stem cell niche are predominantly located at the lowest end of an oxygen gradient in the bone marrow with the implication that regionally defined hypoxia plays a fundamental role in regulating stem cell function.

Citing Articles

Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors.

Daumova L, Manakov D, Petrak J, Sovilj D, Behounek M, Andera L Cell Death Discov. 2025; 11(1):65.

PMID: 39966387 PMC: 11836139. DOI: 10.1038/s41420-025-02341-y.

Enhanced therapeutic effects of hypoxia-preconditioned mesenchymal stromal cell-derived extracellular vesicles in renal ischemic injury.

Yuan F, Liu J, Zhong L, Liu P, Li T, Yang K Stem Cell Res Ther. 2025; 16(1):39.

PMID: 39901252 PMC: 11792194. DOI: 10.1186/s13287-025-04166-z.

IL-27 limits HSPC differentiation during infection and protects from stem cell exhaustion.

Aldridge D, Lanzar Z, Phan A, Christian D, Pardy R, Min B bioRxiv. 2025; .

PMID: 39868131 PMC: 11761129. DOI: 10.1101/2025.01.15.633135.

Hypoxia-adenosinergic regulation of B cell responses.

Pruitt L, Abbott R Front Immunol. 2024; 15:1478506.

PMID: 39559353 PMC: 11570280. DOI: 10.3389/fimmu.2024.1478506.

High Mitophagy and Low Glycolysis Predict Better Clinical Outcomes in Acute Myeloid Leukemias.

Salwa A, Ferraresi A, Vallino L, Maheshwari C, Moia R, Gaidano G Int J Mol Sci. 2024; 25(21).

PMID: 39519080 PMC: 11546612. DOI: 10.3390/ijms252111527.

References

Nilsson S, Johnston H, Coverdale J . Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood. 2001; 97(8):2293-9. DOI: 10.1182/blood.v97.8.2293. View

Holden S, Teicher B, Ara G, Herman T, Coleman C . Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma. J Natl Cancer Inst. 1992; 84(3):187-93. DOI: 10.1093/jnci/84.3.187. View

van Laarhoven H, Bussink J, Lok J, Punt C, Heerschap A, van der Kogel A . Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parameters. Int J Radiat Oncol Biol Phys. 2004; 60(1):310-21. DOI: 10.1016/j.ijrobp.2004.05.014. View

Nishi H, Nakada T, Kyo S, Inoue M, Shay J, Isaka K . Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol. 2004; 24(13):6076-83. PMC: 480902. DOI: 10.1128/MCB.24.13.6076-6083.2004. View

Ceradini D, Kulkarni A, Callaghan M, Tepper O, Bastidas N, Kleinman M . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10(8):858-64. DOI: 10.1038/nm1075. View

Chow D, Wenning L, Miller W, Papoutsakis E . Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J. 2001; 81(2):685-96. PMC: 1301545. DOI: 10.1016/S0006-3495(01)75733-5. View

Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K . Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004; 118(2):149-61. DOI: 10.1016/j.cell.2004.07.004. View

Brown J, Wilson W . Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004; 4(6):437-47. DOI: 10.1038/nrc1367. View

Pearce D, Ridler C, Simpson C, Bonnet D . Multiparameter analysis of murine bone marrow side population cells. Blood. 2003; 103(7):2541-6. DOI: 10.1182/blood-2003-09-3281. View

10.

Goodell M, Rosenzweig M, Kim H, Marks D, Demaria M, Paradis G . Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997; 3(12):1337-45. DOI: 10.1038/nm1297-1337. View

11.

Gustafsson M, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J . Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell. 2005; 9(5):617-28. DOI: 10.1016/j.devcel.2005.09.010. View

12.

Down J, Boudewijn A, van Os R, Thames H, Ploemacher R . Variations in radiation sensitivity and repair among different hematopoietic stem cell subsets following fractionated irradiation. Blood. 1995; 86(1):122-7. View

13.

Ploemacher R, van der Sluijs J, Voerman J, Brons N . An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood. 1989; 74(8):2755-63. View

14.

Matsuzaki Y, Kinjo K, Mulligan R, Okano H . Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity. 2004; 20(1):87-93. DOI: 10.1016/s1074-7613(03)00354-6. View

15.

Schofield R . The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells. 1978; 4(1-2):7-25. View

16.

Calvi L, Adams G, Weibrecht K, Weber J, Olson D, Knight M . Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425(6960):841-6. DOI: 10.1038/nature02040. View

17.

Weissman I, Anderson D, Gage F . Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol. 2001; 17:387-403. DOI: 10.1146/annurev.cellbio.17.1.387. View

18.

Camargo F, Chambers S, Drew E, McNagny K, Goodell M . Hematopoietic stem cells do not engraft with absolute efficiencies. Blood. 2005; 107(2):501-7. PMC: 1895609. DOI: 10.1182/blood-2005-02-0655. View

19.

Cipolleschi M, Dello Sbarba P, Olivotto M . The role of hypoxia in the maintenance of hematopoietic stem cells. Blood. 1993; 82(7):2031-7. View

20.

Zhang J, Niu C, Ye L, Huang H, He X, Tong W . Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425(6960):836-41. DOI: 10.1038/nature02041. View